Geneva Capital Management’s Parexel International Corp PRXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$75.5M Sell
1,197,480
-197,388
-14% -$11.2M 2.21% 2
2014
Q2
$73.7M Sell
1,394,868
-32,035
-2% -$1.61M 1.81% 9
2014
Q1
$77.2M Sell
1,426,903
-24,531
-2% -$1.26M 1.8% 9
2013
Q4
$65.6M Sell
1,451,434
-32,735
-2% -$1.5M 1.49% 27
2013
Q3
$74.5M Sell
1,484,169
-722,923
-33% -$35.4M 1.77% 11
2013
Q2
$101M Buy
+2,207,092
New +$97M 2.03% 8

Other funds holding PRXL

Geneva Capital Management's PRXL Position: Q3 2014 in Review

Geneva Capital Management reduced its Parexel International Corp (PRXL) stake by 14% in Q3 2014, selling an estimated $11.2M and leaving 1,197,480 shares worth $75.5M. The position accounts for 2.21% of the portfolio, ranked #2.

Geneva Capital Management first reported a position in PRXL in Q2 2013 and has held it in 6 quarters since. The position peaked at $101M in Q2 2013. 271 funds tracked by Wall St. Rank hold PRXL as of Q3 2014.

  • Geneva Capital Management held 1,197,480 shares of Parexel International Corp worth $75.5M as of Q3 2014.
  • Geneva Capital Management sold 197,388 Parexel International Corp shares in Q3 2014, an estimated $11.2M.
  • Parexel International Corp made up 2.21% of Geneva Capital Management's portfolio in Q3 2014, its #2 holding.
  • Geneva Capital Management first reported a position in Parexel International Corp in Q2 2013 and has held it in 6 quarters since.
  • Geneva Capital Management's Parexel International Corp position peaked at $101M in Q2 2013.
  • 271 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2014.

Based on Geneva Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.